Only IL-1 and IL-18 polymorphisms in hematological malignancies were linked to clinical and pathophysiological traits in acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Here, IL18 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.